5 min read
Measure Twice, Cut Once: The Value of Target Analysis in Antibody Discovery
Editor’s note: Welcome to 2021, and to our first in a year-long series of posts that will explore the essentials in...
2 min read
The UK Strain and Other Recent RBD Mutations in the SARS-CoV-2 Virus
Examining mutations in the SARS-CoV-2 Spike (S) Protein Receptor Binding Domain (RBD) at the ACE2 receptor S protein...
5 min read
COVID-19 Targets, Tools and Therapeutics (Part 2)
Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...
4 min read
Expanding the Repertoire of Antibody Drug Discovery with Lambda Light-Chain Models
Accessing the Untapped Potential of 33% of Human IgG
Harvard economist Michael Porter, PhD offers a clever observation...
3 min read
Global Spotlight Shines on mRNA Thanks to Pfizer, BioNTech COVID-19 Vaccine Candidate
In the science shot heard ‘round the world, Pfizer and BioNTech announced Monday that their vaccine candidate (aka...
3 min read
COVID-19 Targets, Tools and Therapeutics (Part 1)
Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery,...
4 min read
Women Helping Women Power Through the Pandemic
On July 30th, we had the pleasure of moderating a virtual panel on Antibody Discovery and the Pandemic for the San...
6 min read
News Release: Study Identifies Potential COVID Vaccine & Therapy Research Pathways
Conformational change of the spike protein furin cleavage domain may enhance virus infectivity
June 16, 2020 (Santa...
7 min read
Original Research: Joint effort finds advantages conferred by a D614G mutation in the SARS-CoV-2 spike protein
It’s not often that small biotechnology companies pursue basic research into disease mechanisms. However, the serious...